Cardinal Health (CAH) valuation
Cardinal Health P/E ratio history
Cardinal Health trades at 34.6 times its earnings over the last twelve months. At its last 8 fiscal year ends its P/E ranged from 10.4 (year to Jun 2019) to 75.1 (year to Jun 2023), with a median of 28.0.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Jun 30, 2026 | $237.56 | $7.23 | 32.9 | 21.1 |
| Jun 30, 2025 | $168.00 | $6.45 | 26.0 | 19.0 |
| Jun 30, 2024 | $98.32 | $3.45 | 28.5 | 13.1 |
| Jun 30, 2023 | $94.57 | $1.26 | 75.1 | 14.8 |
| Jun 30, 2022 | $52.27 | -$3.36 | n/m | 9.7 |
| Jun 30, 2021 | $57.09 | $2.08 | 27.5 | 9.3 |
| Jun 30, 2020 | $52.19 | -$12.61 | n/m | — |
| Jun 30, 2019 | $47.10 | $4.53 | 10.4 | — |
| Jun 30, 2018 | $48.83 | $0.81 | 60.1 | — |
| Jun 30, 2017 | $77.92 | $4.03 | 19.4 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Cardinal Health valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Cardinal HealthCAH | $58.7B | 34.6 | — | 0.2 |
| Veeva SystemsVEEV | $50.8B | 51.2 | 32.1 | 14.7 |
| HumanaHUM | $49.8B | 39.1 | 31.6 | 0.3 |
| CignaCI | $78.9B | 12.3 | 9.3 | 0.3 |
| Elevance HealthELV | $91.2B | 17.8 | 14.0 | 0.5 |
| CenteneCNC | $33.8B | 22.7 | 12.6 | 0.2 |
| HCA HealthcareHCA | $102B | 15.7 | 15.3 | 1.3 |
| CVS HealthCVS | $115B | 23.8 | 10.9 | 0.3 |
| LabcorpLH | $29.6B | 29.7 | 18.6 | 2.1 |
| Peer median | 23.3 | 14.6 | 0.4 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: CAH financials · CAH returns
No forecast, no recommendation. This page describes Cardinal Health from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.